BCRX Stock-Based Compensation

Biocryst Pharmaceuticals Inc · Stock-Based Compensation

BCRX logo

BCRX Stock-Based Compensation

Latest reported$121.89M
BCRX TTM Stock-Based Comp ($0.00 → $121.89M)
High-resolution chart · PNG

BCRX stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biocryst Pharmaceuticals Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
121,888,000
128,500,000
133,841,000
82,612,000
81,260,000
73,129,000
65,413,000
60,562,000
55,592,000
55,260,000
55,615,000
54,409,000
52,081,000
49,107,000
44,701,000
37,919,000
40,997,000
38,762,000
34,640,000
32,027,000
21,871,000
17,519,000
14,794,000
12,595,000
15,051,000
17,156,000
17,719,000
16,355,000
13,111,000
9,810,000
9,396,000
9,386,000
12,820,000
13,062,000
12,621,000
12,316,000
8,784,000
8,304,000
8,487,000
8,410,000
8,262,000
10,091,000
9,705,000
11,400,000
10,982,000
10,826,000
10,177,000
7,439,000
6,976,000
4,376,000
4,368,000
4,301,000
4,510,000
4,725,000
4,167,000
4,245,000
4,222,000
4,349,000
4,772,000
5,179,856
5,463,856
6,362,856
6,301,856
6,339,883
6,296,883
5,602,883
5,524,883
5,864,833,000
5,863,448,000
5,861,982,000
5,863,107,000
5,693,481,000
5,693,481,000
5,693,481,000
5,691,028,000
26,392,000
26,399,000
26,405,000
26,405,000
26,405,000
26,411,000
26,708,000
26,721,000
512,756,000
512,744,000
512,441,000
512,428,000
119,677,000
119,676,000
119,676,000
119,676,000
120,190,000
120,190,000
120,190,000
120,190,000
123,289,000
123,289,000
123,289,000
123,289,000
104,529,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.